Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR-DMD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by University of Rochester
Sponsor:
Collaborators:
Newcastle University
University Medical Center Freiburg
Information provided by (Responsible Party):
Robert Griggs, MD, University of Rochester
ClinicalTrials.gov Identifier:
NCT01603407
First received: April 3, 2012
Last updated: November 17, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)